Does TENS Therapy Really Work? What the Research Actually Shows About Migraines, Pain, Anxiety, and Sleep

Walk through the headache-relief aisle of any pharmacy, or scroll past a sponsored ad for a sleek headband-style device, and you’ll see the same pitch: a small electrical current applied to your skin or scalp that promises to ease migraines, calm chronic pain, quiet anxiety, or help you finally get a full night’s sleep. These devices go by a few names — TENS (transcutaneous electrical nerve stimulation), e-TNS (external trigeminal nerve stimulation), and CES (cranial electrotherapy stimulation) — and the marketing usually leans on a long list of academic citations to make the case.

But a long reference list isn’t the same as strong evidence. Some of these citations point to large, well-designed, sham-controlled trials. Others are single small studies from decades ago, or papers about a completely different intervention that got lumped in anyway. If you’re deciding whether to spend $100–$300 on one of these devices, it’s worth knowing which claims are backed by real data and which ones are riding on the coattails of a plausible-sounding mechanism.

We went through the primary research behind the most commonly cited claims for TENS and CES devices — migraine treatment, chronic pain, anxiety and depression, and insomnia — and graded the evidence for each. Here’s what actually holds up.

What Is TENS, and How Is It Different From CES?

Both technologies work by sending a low-level electrical current through electrodes placed on the skin, but they target different things and are used for different problems.

TENS (transcutaneous electrical nerve stimulation) applies current to peripheral nerves — often on the forehead, neck, or wherever pain is localized. The leading theory is that it interferes with pain signals traveling to the brain (a version of the “gate control” theory of pain) and may trigger the release of the body’s own natural pain-relieving chemicals. A specific type called e-TNS (external trigeminal nerve stimulation) targets the trigeminal nerve via the forehead and is the version most often marketed specifically for migraine.

CES (cranial electrotherapy stimulation) is a different animal. Instead of targeting a peripheral nerve for pain, it sends a very low-intensity current across the head — typically via electrodes clipped to the earlobes — with the stated goal of influencing brain activity related to mood, anxiety, and sleep. It’s FDA-cleared for anxiety, depression, and insomnia, though as you’ll see below, “cleared” and “proven effective” aren’t the same regulatory bar.

Conflating the two is one of the most common issues in device marketing: a claim proven for TENS on migraine gets visually and narratively blended with a much shakier CES claim about sleep, as if it’s all one body of evidence for one mechanism. It isn’t.

TENS for Acute Migraine Attacks: The Strongest Evidence on This List

If there’s one claim in this space that’s genuinely well-supported, it’s using e-TNS to treat a migraine attack as it’s happening.

A 2021 randomized controlled trial published in The American Journal of Emergency Medicine tested TENS therapy on patients arriving at the emergency department mid-migraine, comparing a real device against a visually identical sham device. Neither patients nor the group administering treatment knew who was getting the active stimulation. The trial found meaningful reductions in reported pain at both the 20-minute and 120-minute marks in the group receiving real stimulation, compared to sham.

The stronger piece of evidence, though, is the 2022 TEAM trial, published in Scientific Reports — a Phase 3, multicenter, double-blind, sham-controlled study involving 538 adult migraine patients. Participants used a 2-hour continuous e-TNS treatment (the Cefaly device) at home during a single moderate-to-severe migraine attack. The active-treatment group showed statistically significant improvements over sham on the two primary endpoints: freedom from pain and freedom from the most bothersome associated symptom (like nausea or light sensitivity) at the two-hour mark, with benefits still visible at 24 hours.

What makes this trial notable isn’t just the positive result — it’s the size and design. Nearly 540 participants with proper blinding and a real sham comparator is a much higher evidentiary bar than most device studies clear. If you’re looking for the single most trustworthy claim in this entire category, “e-TNS can reduce pain during an acute migraine attack” is it.

TENS for Migraine Prevention: Promising, But Thinner

A different claim — that daily use of a supraorbital TENS device can prevent migraines from happening in the first place — rests mainly on one key trial: the 2013 PREMICE study published in Neurology, which tested the same Cefaly device used preventively, for 20 minutes a day over three months, in patients with at least two migraines a month.

The results were positive: migraine frequency dropped significantly in the group using the real device, while the sham group saw no significant change. But this was a single trial with only 67 participants, and follow-up literature has since classified it as “Class III evidence” — a real, useful data point, but not the kind of large, replicated result that lets you say prevention is definitively proven. It’s a reasonable option to try, particularly for people who’ve had side effects with preventive medications, but it shouldn’t be marketed with the same confidence as the acute-treatment research above.

TENS for Chronic Pain, More Broadly: Good Theory, Inconsistent Proof

Beyond migraine, TENS is widely marketed as a general chronic pain solution — for back pain, arthritis, and nerve pain. The mechanistic case for this is solid: a frequently cited 2003 review in The Journal of Pain lays out, in detail, how TENS affects the nervous system, including its interaction with the body’s own opioid and non-opioid pain-modulating pathways. This is genuinely useful background for understanding why TENS might work.

But here’s the catch that a lot of marketing pages skip over: explaining a plausible mechanism is not the same as demonstrating a clinical benefit. Broader systematic reviews of TENS for chronic pain conditions have repeatedly run into the same wall — most existing trials are small, poorly blinded (it’s hard to disguise the tingling sensation of real stimulation), or inconsistent in their protocols, which makes it difficult to draw a firm conclusion either way. TENS may well help some people with chronic pain, and the biological rationale is sound, but “chronic pain relief” as a general claim currently rests on weaker ground than the acute-migraine claim above.

CES for Anxiety and Depression: More Nuanced Than It Looks

This is where the evidence picture gets genuinely mixed, and where it’s worth being precise rather than lumping everything together.

On the encouraging side, more recent meta-analyses (pooling multiple randomized trials) have found that CES outperforms sham stimulation for anxiety symptoms, with a moderate effect size across several hundred pooled patients. Some of these analyses found a comparable benefit for depression symptoms and for insomnia specifically among people who also had anxiety.

On the more cautious side, a Cochrane systematic review focused specifically on CES for acute depression found that none of the available trials met basic quality standards — meaning none used a properly blinded sham, a standardized diagnostic process, and validated outcome measures all together. A separate large systematic review found that the vast majority of CES trials across all conditions were at high risk of bias, largely because sham devices don’t reproduce the mild tingling sensation of active stimulation, making it easy for participants to guess which group they’re in. That same review found a positive signal for anxiety and mild headache benefit, but no significant benefit for insomnia or general cognitive function once only the better-designed studies were considered.

A frequently cited older paper from 2003, published in the Journal of Alternative and Complementary Medicine, is often used to support the pain-and-depression connection for this technology, but it predates virtually all of the quality standards that later reviews have applied — it’s a real, historically important paper, but not one that should be treated as current best evidence.

The honest summary: CES has a reasonable, if not airtight, case for anxiety relief. Its case for depression and insomnia is considerably weaker and depends heavily on which studies you include.

Electrical Stimulation for Insomnia: The Weakest Claim, and a Common Mix-Up

Insomnia is where marketing citation lists tend to get sloppiest. One frequently cited 2011 paper on autonomic nervous system activation and insomnia, published in the Journal of Clinical Sleep Medicine, is actually a study of acupuncture — not TENS, not CES, not any form of electrical stimulation. It’s a legitimate paper about a genuinely different intervention, and its presence on TENS/CES reference lists is a good example of citation-stacking: including a paper that sounds topically related to pad out the evidence, even though it doesn’t actually test the product being sold.

When you look specifically at trials that do test CES for insomnia with a proper sham comparison, the picture is unimpressive. Pooled results from higher-quality studies have found no significant benefit for insomnia specifically, even in analyses that found benefits for anxiety and headache using the same technology. If sleep is your primary reason for considering one of these devices, it’s currently the least evidence-backed use case on this list.

Who Might Reasonably Try TENS or CES — and Who Should Be Cautious

Given where the evidence actually stands, here’s a practical way to think about it:

• Good candidates for e-TNS: People who experience migraines and want a non-drug option to use during an attack, particularly those who’ve had side effects from or contraindications to standard migraine medications.
• Reasonable to try, with modest expectations: People considering daily preventive TENS for frequent migraines, or CES specifically for anxiety symptoms.
• Worth more skepticism: Claims that TENS or CES will meaningfully treat general chronic pain, clinical depression, or insomnia as a primary complaint. The evidence here is thin, inconsistent, or borrowed from studies of a different intervention entirely.

As with any device, people with implanted electronic devices like pacemakers, epilepsy, or pregnancy should check with a doctor before using TENS or CES, since most trials specifically excluded these groups.

What to Look For If You Decide to Try One

If you’re evaluating a specific device, a few practical questions can help you separate real evidence from a well-designed reference list:

• Was the underlying research done on this specific device, or a similar-sounding one? Evidence for the Cefaly device doesn’t automatically transfer to a different brand’s headband.
• Was the trial sham-controlled and blinded? Given how hard it is to disguise the sensation of active stimulation, this matters more here than in most device categories.
• Is the claim being made actually the claim the study tested? “Reduces migraine pain during an attack” and “prevents migraines” and “treats chronic pain” are three different claims requiring three different kinds of evidence — don’t let one strong trial cover for two weak ones.

Frequently Asked Questions

Does TENS actually work for migraines?
For treating an active migraine attack, yes — this is the best-supported use case, backed by a large, sham-controlled Phase 3 trial (the TEAM study) and a separate emergency department RCT. For migraine prevention, the evidence is positive but comes mainly from one smaller trial.

Is cranial electrotherapy stimulation (CES) FDA-approved?
CES devices are FDA-cleared for insomnia, anxiety, and depression, but regulatory clearance in this category doesn’t require the same level of proof as full FDA approval for a new drug. Clearance reflects safety and “substantial equivalence” to existing devices more than it reflects strong efficacy data.

Can TENS or CES help with sleep?
The evidence here is weak. Higher-quality trials specifically testing CES for insomnia have generally not found a significant benefit, even when the same studies found benefits for anxiety.

Are TENS and CES the same thing?
No. TENS typically targets peripheral nerves (like the trigeminal nerve on the forehead) for pain conditions like migraine. CES applies current across the head, usually via the earlobes, and is aimed at brain-mediated conditions like anxiety, depression, and insomnia.

The Bottom Line

Not all electrical stimulation claims are created equal. The case for using e-TNS to interrupt an active migraine attack is genuinely strong, resting on a large, well-designed, sham-controlled trial. The case for migraine prevention is positive but based on thinner evidence. And the case for chronic pain, anxiety, depression, and especially insomnia ranges from mixed to weak — with at least one commonly cited paper actually testing acupuncture rather than electrical stimulation at all.

None of this means these devices are useless. It means the marketing language often outruns what the research supports, and a shopper (or a clinician) deserves to know which claims to trust and which to treat as a hypothesis rather than a proven fact.